Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma
- Resource Type
- Article
- Source
- In
Blood Advances 14 November 2023 7(21):6579-6588 - Subject
Clinical Trials and Observations Lymphoid Neoplasia - Language
- ISSN
- 2473-9529